Compensation award — excluded from discretionary-purchase analysis.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
View the official recordSEC Form 4 — Statement of Changes in Beneficial OwnershipAll the details
Dates, kept separate
Transaction date
May 14, 2026
Reporting period
Not applicable
Filed with the SEC
May 19, 2026
DirectorGrant / award
Context
Classification
grant award
Code A — grant or award
Planned / mechanical clue
None found in footnotes
Only flagged when a footnote says so; never inferred
Source receipt
Record ID
0001193125-26-228896
Filed / recorded
May 19, 2026, 12:05 AM UTC
Added to OQRO
Oct 6, 2026, 8:46 PM UTC
Parser
form4-xml-v2
Data quality
Verified: identifiers matched exactly
Issuer
REPLIGEN CORP
Issuer CIK
730272
Ticker
RGEN
Reporting person
Martin D Madaus
Relationship
Director
Security
Stock Option (Right to Buy)
Table
Derivative (Table II)
Transaction date
May 14, 2026
Transaction code
A
Shares / units
2,239
Price per share
$0.00
Acquired / disposed
Acquired (A)
Shares owned after
2,239
Ownership form
Direct
Amendment
No
Footnotes from the filing
Award vests in full on the earlier of May 14, 2027, one year from grant date, or on the date of the next annual meeting of the Company's shareholders, which has not yet been determined.